Press "Enter" to skip to content

Pfizer signs deal to allow broader global access to its Covid-19 antiviral pill

Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill.

Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *